A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.

@article{Prager2002ARD,
  title={A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia.},
  author={Nelson A. Prager and Kate Bickett and Nita French and Geno Marcovici},
  journal={Journal of alternative and complementary medicine},
  year={2002},
  volume={8 2},
  pages={
          143-52
        }
}
BACKGROUND Androgenetic alopecia (AGA) is characterized by the structural miniaturization of androgen-sensitive hair follicles in susceptible individuals and is anatomically defined within a given pattern of the scalp. [] Key MethodSUBJECTS Included in this study were males between the ages of 23 and 64 years of age, in good health, with mild to moderate AGA. RESULTS The results of this pilot study showed a highly positive response to treatment.

Figures and Tables from this paper

Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study
TLDR
In men with hair loss in the vertex area of the scalp, the combination of 5% hexane extract of C. aeruginosa and 5% minoxidil slowed hair loss and increased hair growth.
An Open-Label Evaluator Blinded Study of the Efficacy and Safety of a New Nutritional Supplement in Androgenetic Alopecia: A Pilot Study.
TLDR
Preliminary results indicate that Forti5® a novel nutritional supplement that contains cholecalciferol, omega 3 and 6 fatty acids, melatonin, antioxidants, and botanical 5-alpha reductase inhibitors, may be a useful adjunct in the treatment of androgenetic alopecia.
A preliminary study on topical cetirizine in the therapeutic management of androgenetic alopecia
TLDR
The results have shown that topical cetirizine 1% is responsible for a significant improvement of the initial framework of AGA, with an increase in total hair density, terminal hair density and diameter variation from T0 to T1, while the vellus hair density shows an evident decrease.
Blockade of Androgen Markers Using a Novel Betasitosterol, Thioctic Acid and Carnitine‐containing Compound in Prostate and Hair Follicle Cell‐based Assays
TLDR
These studies provide proof of concept that novel, naturally derived compositions simultaneously targeting 5AR and inflammatory mediators may represent a rational approach to treating AGA and BPH.
A proprietary herbal extract against hair loss in androgenetic alopecia and telogen effluvium: a placebo-controlled, single-blind, clinical-instrumental study.
TLDR
Herbal formulations were found to be more effective in preventing and reducing hair loss than placebo at every assessment point, and eutrophic effect for scalp hair is interpreted as the final outcome of the entire content of the herbal formula.
A Systemic Review on Topical Marketed Formulations, Natural Products, and Oral Supplements to Prevent Androgenic Alopecia: A Review
TLDR
A widespread review of topical marketed formulations, natural products, and CAM treatment options for Androgenic alopecia is offered.
Multi‐therapies in androgenetic alopecia: review and clinical experiences
TLDR
The treatment for AGA should be based on personalized therapy and targeted at the different pathophysiological aspects of AGA, since the benefit will not be maintained upon ceasing therapy.
A Comprehensive Review of Natural Alternatives for Treatment of Alopecia with an Overview of Market Products.
TLDR
This study presents a review of reported herbal remedies and herb combinations recommended for hair loss and their mode of action, along with an overview of available market products and formulations, their composition, and declared effects.
...
...

References

SHOWING 1-10 OF 56 REFERENCES
A Randomized , Double-Blind , Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5 AR in the Treatment of Androgenetic Alopecia
TLDR
The first example of a placebocontrolled, double-blind study undertaken in order to examine the benefit of these botanical substances in the treatment of Androgenetic alopecia is reported.
[Therapy of androgenetic alopecia with finasteride. What must be considered in consultation and drug prescribing].
TLDR
The efficacy of finasteride 1 mg has been demonstrated in a randomized, double-blind, placebo-controlled clinical trial involving more than 1,500 men in whom a significant increase in hair density over a specified area of the scalp, and a significant improvement in appearance was noted.
[Is there a rational therapy for symptomatic treatment of benign prostatic hyperplasia with phytogenic drugs? Illustrated with the example of the prostate agent from Serenoa repens (Sabal fructus)].
TLDR
Both groups of substances are useful for individualized treatment of benign prostatic hyperplasia (BPH), provided that conservative pharmacological treatment of BPH is basically accepted and that the patients' quality of life is also considered.
Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial.
TLDR
In patients with pubertal gynecomastia, no significant difference in the percentage of patients with a 50% or greater reduction in total breast volume, as calculated from ultrasonography measurements, was demonstrated between the anastrozole and placebo groups.
Finasteride, a Type 2 5alpha-reductase inhibitor, in the treatment of men with androgenetic alopecia.
TLDR
Clinical studies in balding men demonstrated that finasteride reduced scalp DHT levels and improved hair growth, confirming the role of DHT in the pathophysiology of AGA.
[Status of phytotherapeutic drugs in treatment of benign prostatic hyperplasia].
TLDR
A critical analysis of the data available suggests that the effects of phytotherapy are no better than those of placebo treatment, and further studies are urgently needed to compare the results with those of chemically defined drugs that seem to have a beneficial influence on the pathomechanism underlying symptomatic BPH.
Preventing diseases of the prostate in the elderly using hormones and nutriceuticals
  • F. Comhaire, A. Mahmoud
  • Medicine, Biology
    The aging male : the official journal of the International Society for the Study of the Aging Male
  • 2004
TLDR
A strategy to prevent prostate cancer is suggested that aims at providing men with partial androgen deficiency correct testosterone substitution with a sustained release buccal bio-adhesive tablet and Serenoa seems to exert anti-inflammatory and complementary cellular actions with beneficial effects on the prostate.
Herbs for Benign Prostatic Hyperplasia
TLDR
There are many European studies examining efficacy, dose, and adverse effects of these plants in the treatment of BPH, however, numerous questions remain.
Mechanism of action of androgen in hair follicles.
Phytotherapy for benign prostatic hyperplasia
TLDR
Randomized studies of Serenoa repens, alone or in combination with other plant extracts, have provided the strongest evidence for efficacy and tolerability in treatment of BPH in comparison with other phytotherapies.
...
...